Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cárdenas-Navia, L. I.
Right arrow Articles by Dewhirst, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cárdenas-Navia, L. I.
Right arrow Articles by Dewhirst, M. W.
[Cancer Research 64, 6010-6017, September 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Tumor-dependent Kinetics of Partial Pressure of Oxygen Fluctuations during Air and Oxygen Breathing

L. Isabel Cárdenas-Navia1, Daohai Yu2, Rod D. Braun3, David M. Brizel1, Timothy W. Secomb4 and Mark W. Dewhirst1

Departments of 1 Radiation Oncology and 2 Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina; 3 Department of Anatomy/Cell Biology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan; and 4 Department of Physiology, Arizona Health Sciences Center University of Arizona, Tucson, Arizona

The primary purpose of this study was to examine the kinetics of partial pressure of oxygen (pO2) fluctuations in fibrosarcoma (FSA) and 9L tumors under air and O2 breathing conditions. The overall hypothesis was that key factors relating to oxygen tension fluctuations would vary between the two tumor types and as a function of the oxygen content of the breathing gas. To assist in the interpretation of the temporal data, spatial pO2 distributions were measured in 10 FSA and 8 9L tumors transplanted into the subcutis of the hind leg of Nembutal-anesthetized (50 mg/kg) Fischer 344 rats. Recessed-tip oxygen microelectrodes were inserted into the tumor, and linear pO2 measurements were recorded in 50-µm steps along a 3-mm path, and blood pressure was simultaneously measured via femoral arterial access. Additionally, pO2 was measured at a single location for 90 to 120 minutes in FSA (n = 11) or 9L tumors (n = 12). Rats were switched from air to 100% O2 breathing after 45 minutes. Temporal pO2 records were evaluated for their potential radiobiological significance by assessing the number of times they crossed a 10-mm-Hg threshold. In addition, the data were subjected to Fourier analysis for air and O2 breathing.

FSA and 9L tumors had spatial median pO2 measurements of 4 and 1 mm Hg, respectively. 9L had more low pO2 measurements ≤2.5 mm Hg than did FSA, whereas between 2.5 and 10 mm Hg this pattern was reversed. Pimonidazole staining patterns in FSA and 9L tumors supported these results. Temporal pO2 instability was observed in all experiments during air and O2 breathing. Threshold analyses indicated that the 10 mm Hg threshold was crossed 2 to 5 times per hour, independent of tumor type. However, the magnitude of 9L pO2 fluctuations was approximately eight times greater than FSA fluctuations, as assessed with Fourier transform analysis (Wilcoxon, P < 0.005). O2 breathing significantly increased median pO2 in FSA from 3 to 8 mm Hg (P < 0.005) and caused a significant increase in frequency and magnitude of pO2 fluctuations. One hundred percent O2 breathing had no effect on 9L tumor pO2, and it decreased the magnitude of pO2 fluctuations with borderline significance.

These results show that these two tumors differ significantly with respect to spatial and temporal oxygenation conditions under air and O2 breathing. Fluctuations of pO2 of the type reported herein are predicted to significantly affect radiotherapy response and could be a source for genetic instability, increased angiogenesis, and metastases.




This article has been cited by other articles:


Home page
JNMHome page
C. J. Yeom, J.-K. Chung, J. H. Kang, Y. H. Jeon, K. I. Kim, Y. N. Jin, Y. M. Lee, J. M. Jeong, and D. S. Lee
Visualization of Hypoxia-Inducible Factor-1 Transcriptional Activation in C6 Glioma Using Luciferase and Sodium Iodide Symporter Genes
J. Nucl. Med., September 1, 2008; 49(9): 1489 - 1497.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. I. Cardenas-Navia, D. Mace, R. A. Richardson, D. F. Wilson, S. Shan, and M. W. Dewhirst
The Pervasive Presence of Fluctuating Oxygenation in Tumors
Cancer Res., July 15, 2008; 68(14): 5812 - 5819.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Picchio, R. Beck, R. Haubner, S. Seidl, H.-J. Machulla, T. D. Johnson, H.-J. Wester, G. Reischl, M. Schwaiger, and M. Piert
Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD Autoradiography
J. Nucl. Med., April 1, 2008; 49(4): 597 - 605.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. K. Rofstad, K. Galappathi, B. Mathiesen, and E.-B. M. Ruud
Fluctuating and Diffusion-Limited Hypoxia in Hypoxia-Induced Metastasis
Clin. Cancer Res., April 1, 2007; 13(7): 1971 - 1978.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. R. Laderoute, K. Amin, J. M. Calaoagan, M. Knapp, T. Le, J. Orduna, M. Foretz, and B. Viollet
5'-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments.
Mol. Cell. Biol., July 1, 2006; 26(14): 5336 - 5347.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. Koumenis and B. G. Wouters
"Translating" Tumor Hypoxia: Unfolded Protein Response (UPR)-Dependent and UPR-Independent Pathways
Mol. Cancer Res., July 1, 2006; 4(7): 423 - 436.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Yuan, T. Schroeder, J. E. Bowsher, L. W. Hedlund, T. Wong, and M. W. Dewhirst
Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent 64Cu(II)-Diacetyl-Bis(N4-Methylthiosemicarbazone)
J. Nucl. Med., June 1, 2006; 47(6): 989 - 998.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Lanzen, R. D. Braun, B. Klitzman, D. Brizel, T. W. Secomb, and M. W. Dewhirst
Direct Demonstration of Instabilities in Oxygen Concentrations within the Extravascular Compartment of an Experimental Tumor
Cancer Res., February 15, 2006; 66(4): 2219 - 2223.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. Cairns, I. Papandreou, and N. Denko
Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment
Mol. Cancer Res., February 1, 2006; 4(2): 61 - 70.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. E. Thelwall, A. Y. Yemin, T. L. Gillian, N. E. Simpson, M. S. Kasibhatla, Z. N. Rabbani, J. M. Macdonald, S. J. Blackband, and M. P. Gamcsik
Noninvasive In vivo Detection of Glutathione Metabolism in Tumors
Cancer Res., November 15, 2005; 65(22): 10149 - 10153.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.